PLAT, plasminogen activator, tissue type, 5327

N. diseases: 392; N. variants: 7
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0019080
Disease: Hemorrhage
Hemorrhage
0.300 Biomarker phenotype CTD_human Fibrin(ogen)-independent role of plasminogen activators in acetaminophen-induced liver injury. 22507835 2012
CUI: C0019080
Disease: Hemorrhage
Hemorrhage
0.300 Biomarker phenotype CTD_human Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. 15016487 2004
CUI: C0019080
Disease: Hemorrhage
Hemorrhage
0.300 Biomarker phenotype CTD_human Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke. 15502123 2004
CUI: C0019080
Disease: Hemorrhage
Hemorrhage
0.300 Biomarker phenotype CTD_human Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis. 9266785 1997
CUI: C0019080
Disease: Hemorrhage
Hemorrhage
0.300 Biomarker phenotype CTD_human Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism. The Coagulation Project Investigators of the Bolus Alteplase Pulmonary Embolism Group. 9199818 1997
CUI: C0019080
Disease: Hemorrhage
Hemorrhage
0.300 Biomarker phenotype CTD_human Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group. 8082347 1994
CUI: C0019080
Disease: Hemorrhage
Hemorrhage
0.300 Biomarker phenotype CTD_human Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. 8427107 1993
CUI: C0019080
Disease: Hemorrhage
Hemorrhage
0.300 Biomarker phenotype CTD_human Local low dose intra-arterial thrombolytic therapy: the risk of stroke or major haemorrhage. 2514002 1989